Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Distinct functional domains of Nbs1 modulate the timing and magnitude of ATM activation after low doses of ionizing radiation

Z Horejsi, J Falck, CJ Bakkenist, MB Kastan, J Lukas, J Bartek

. 2004 ; 23 (17) : 3122-3127.

Language English Country England, Great Britain

E-resources Online Full text

NLK Free Medical Journals from 1997 to 2004
ProQuest Central from 2000-01-01 to 1 year ago
Open Access Digital Library from 1997-01-01
Medline Complete (EBSCOhost) from 1997-01-09 to 2015-11-26
Health & Medicine (ProQuest) from 2000-01-01 to 1 year ago
Public Health Database (ProQuest) from 2000-01-01 to 1 year ago

The ATM kinase is a tumour suppressor and a key activator of genome integrity checkpoints in mammalian cells exposed to ionizing radiation (IR) and other insults that elicit DNA double-strand breaks (DSBs). In response to IR, autophosphorylation on serine 1981 causes dissociation of ATM dimers and initiates cellular ATM kinase activity. Here, we show that the kinetics and magnitude of ATM Ser1981 phosphorylation after exposure of human fibroblasts to low doses (2 Gy) of IR are altered in cells deficient in Nbs1, a substrate of ATM and a component of the MRN (Mre11-Rad50-Nbs1) complex involved in processing/repair of DSBs and ATM-dependent cell cycle checkpoints. Timely phosphorylation of both ATM Ser1981 and the ATM substrate Smc1 after IR were rescued via retrovirally mediated reconstitution of Nbs1-deficient cells by wild-type Nbs1 or mutants of Nbs1 defective in the FHA domain or nonphosphorylatable by ATM, but not by Nbs1 lacking the Mre11-interaction domain. Our data indicate that apart from its role downstream of ATM in the DNA damage checkpoint network, the MRN complex serves also as a modulator/amplifier of ATM activity. Although not absolutely required for ATM activation, the MRN nuclease complex may help reach the threshold activity of ATM necessary for optimal genome maintenance and prevention of cancer.

000      
00000naa a2200000 a 4500
001      
bmc14079645
003      
CZ-PrNML
005      
20141120141146.0
007      
ta
008      
141120s2004 enk f 000 0|eng||
009      
AR
035    __
$a (PubMed)15048089
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Hořejší, Zuzana $7 xx0122010 $u Danish Cancer Society, Institute of Cancer Biology, Strandboulevarden 49, Copenhagen DK-2100 Denmark.
245    10
$a Distinct functional domains of Nbs1 modulate the timing and magnitude of ATM activation after low doses of ionizing radiation / $c Z Horejsi, J Falck, CJ Bakkenist, MB Kastan, J Lukas, J Bartek
520    9_
$a The ATM kinase is a tumour suppressor and a key activator of genome integrity checkpoints in mammalian cells exposed to ionizing radiation (IR) and other insults that elicit DNA double-strand breaks (DSBs). In response to IR, autophosphorylation on serine 1981 causes dissociation of ATM dimers and initiates cellular ATM kinase activity. Here, we show that the kinetics and magnitude of ATM Ser1981 phosphorylation after exposure of human fibroblasts to low doses (2 Gy) of IR are altered in cells deficient in Nbs1, a substrate of ATM and a component of the MRN (Mre11-Rad50-Nbs1) complex involved in processing/repair of DSBs and ATM-dependent cell cycle checkpoints. Timely phosphorylation of both ATM Ser1981 and the ATM substrate Smc1 after IR were rescued via retrovirally mediated reconstitution of Nbs1-deficient cells by wild-type Nbs1 or mutants of Nbs1 defective in the FHA domain or nonphosphorylatable by ATM, but not by Nbs1 lacking the Mre11-interaction domain. Our data indicate that apart from its role downstream of ATM in the DNA damage checkpoint network, the MRN complex serves also as a modulator/amplifier of ATM activity. Although not absolutely required for ATM activation, the MRN nuclease complex may help reach the threshold activity of ATM necessary for optimal genome maintenance and prevention of cancer.
536    __
$c Grant Number: CA 21765 (United States NCI NIH HHS)
536    __
$c Grant Number: CA 71387 (United States NCI NIH HHS)
590    __
$a bohemika - dle Pubmed
650    02
$a teleangiektatická ataxie $7 D001260
650    02
$a ATM protein $7 D064007
650    02
$a vazebná místa $7 D001665
650    02
$a proteiny buněčného cyklu $x chemie $x metabolismus $7 D018797
650    02
$a viabilita buněk $7 D002470
650    02
$a poškození DNA $x genetika $7 D004249
650    02
$a DNA vazebné proteiny $7 D004268
650    02
$a amplifikace genu $7 D005784
650    02
$a lidé $7 D006801
650    02
$a kinetika $7 D007700
650    02
$a nádory $x genetika $x prevence a kontrola $7 D009369
650    02
$a jaderné proteiny $x chemie $x metabolismus $x nedostatek $7 D009687
650    02
$a fosforylace $7 D010766
650    02
$a fosfoserin $x metabolismus $7 D010768
650    12
$a protein-serin-threoninkinasy $x metabolismus $x účinky záření $7 D017346
650    02
$a ionizující záření $7 D011839
650    02
$a nádorové supresorové proteiny $7 D025521
700    1_
$a Falck, J.
700    1_
$a Bakkenist, C.J.
700    1_
$a Kastan, M.B.
700    1_
$a Lukáš, Jiří $7 xx0094305
700    1_
$a Bártek, Jiří, $d 1953- $7 xx0046271
773    0_
$t Oncogene $x 0950-9232 $g Roč. 23, č. 17 (2004), s. 3122-3127 $p Oncogene $w MED00003600
773    0_
$p Oncogene $g 23(17):3122-7, 2004 Apr 15 $x 0950-9232
910    __
$a ABA008 $y 4 $z 0
990    __
$a 20141120141132 $b ABA008
991    __
$a 20141120141227 $b ABA008
999    __
$a ok $b bmc $g 1047990 $s 878664
BAS    __
$a 3
BMC    __
$a 2004 $b 23 $c 17 $d 3122-3127 $x MED00003600 $i 0950-9232 $m Oncogene $n Oncogene
LZP    __
$a NLK 2014-1/lp

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...